| 摘要 |
<p>Affective disorders in humans are treated by enhancing glutamatergic transmission. This is achieved in various ways, one of which is by the administration of a class of therapeutic agents having a phenyl ketone-containing molecular structure and similar to the structure of aniracetam. This discovery is based on tests using REM sleep reduction in an animal model as an indicator.</p> |
